Klaria’s CEO Jesper Wiklund has acquired shares in Klaria today

Klaria’s CEO Jesper Wiklund today, Wednesday March 24[th], 2021 acquired shares in Klaria Pharma. 

The trades were made on NASDAQ Frist North.  Jesper Wiklund acquired 41,483 shares at an average price of SEK 6.87 for a total purchase of ca 285,000 SEK.

Download as PDF